Nursing Intervention of Negative Emotion in Patients with Viral Hepatitis Treated with Interferon
Abstract
Keywords
Full Text:
PDFReferences
Li, L.H., Cai, L.Zh., Liu, X.F., et al., 2020. Side effects and inter- vention of interferon in the treatment of chronic viral hepatitis. Chinese Journal of nosocomial infection. 30(12), 1845-1850.
Liu, Y.T., 2020. Effect of entecavir combined with interferon α-2α on HBV-DNA negative conversion in patients with viral hepatitis B. Systems medicine. 5(1), 16-18.
Liu, Z.L., 2020. Effect of entecavir combined with pegylated in- terferon α-2a on HBV-DNA negative and serum YKL-40 and CEA levels in patients with viral hepatitis B. Maternal infant world. (27), 133.
Miao, X.L., 2020. Adverse reactions of pegylated interferon α-2α(pegylated interferon) in the treatment of chronic hepatitis C. Drug evaluation. 17(3), 12-13,15.
Zhang, Ch., Shang, L., 2020. Adefovir dipivoxil combined with recombinant human interferon α2b injection in the treatment of pa- tients with viral hepatitis B. Clinical medical research and practice. 5(5), 46-48.
Guo, Y., 2019. Clinical efficacy and safety of entecavir combined with pegylated interferon α-2a in the treatment of chronic hepatitis B. Northern pharmacy. 16(1), 170-171.
Tang, M.G., Tang, J.Sh., 2020. Tenofovir and entecavir for the treatment of hepatitis B virus positive chronic hepatitis with inef- fective interferon. Heilongjiang medicine. 44(12), 1709-1712.
DOI: https://doi.org/10.12346/jnp.v2i1.6283
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Yue Liu, Feng Min, Jianyun Xu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.